Synapse Open Synapse
Biology

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Nature Biological Sciences · · 2 min read

Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.

Same story elsewhere

Latest from Nature Biological Sciences